Cytoflavin in polychemotherapy of breast cancer
Kashuro, V.A.; Glushkov, S.I.; Zheregelia, S.N.
Antibiotiki i Khimioterapiia 55(7-8): 30-33
2010
ISSN/ISBN: 0235-2990 PMID: 21140562 Document Number: 640847
The efficacy of cytoflavin as a supporting drug in the CAF chemotherapy of breast cancer was studied. It was estimated by the tolerability, the peripheric blood index dynamics, the patients general condition (Karnovsky Index) and the frequency of the side effects. For the immediate estimation of the polychemotherapy and cytoflavin effects on the cytoprotection natural system state, the dynamics of the glutathione metabolism and the lipid peroxidation in the erythrocytes was investigated.
Document emailed within 1 workday
Related Documents
Kanaev, S.V.; Krivorot'ko, P.V.; Novikov, S.N.; Semiglazov, V.F.; Semiglzova, T.I.; Turkevich, E.A.; Zhukova, L.A.; Klimashevskiĭ, V.F.; Ivantsov, A.O.; Donskikh, R.V.; Klimenko, V.V.; Briantseva, Z.V. 2013: Effectiveness of mammary scintigraphy for determining the results of neoadjuvant polychemotherapy in breast cancer Voprosy Onkologii 59(3): 328-333Pannuti, F. 1977: Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy Minerva Chirurgica 32(19): 1211-1220
Gudurić, B.; Semnic, R.; Sterio, B. 1977: Our experiences with mono-and polychemotherapy in carcinoma of the breast Medicinski Pregled 30(3-4): 173-176
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Violante, A.; Martinoli, L.; Terzoli, E.; Nisticò, C.; Beciani, M. 1985: Assay of vitamin C in subjects with cancer before and after polychemotherapy Bollettino della Societa Italiana di Biologia Sperimentale 61(7): 983-987
Klapdor, R.; Bahlo, M.; Babinski, A.; Broemel, T.; Müller, C.; Seutter, R. 2003: Sequential polychemotherapy in exocrine pancreatic cancer Anticancer Research 23(2a): 841-844
Sighart, H.; Wrbka, E.; Simml, G. 1972: Intermittent polychemotherapy in inoperable bronchial cancer Wiener Medizinische Wochenschrift 122(33): 485-489
Marino, P.; Pampallona, P.M. 1993: Polychemotherapy in advanced non-small-cell lung cancer Lancet 342(8873): 741; Author Reply 741-2
Zhuchenko, A.P.; Kalganov, I.D.; Filon, A.F.; Totikov, M.Z. 2004: Systemic polychemotherapy in combined treatment of colon cancer Antibiotiki i Khimioterapiia 49(12): 26-30
Lisetskiĭ, V.A.; Evtushenko, G.V.; Dotsenko, I.S.; Svintsitskiĭ, V.S. 1990: Hemosorption and polychemotherapy with hyperglycemia in the treatment of ovarian cancer Vrachebnoe Delo 4: 87-89
Shchepotin, I.B.; Chernyĭ, V.A.; Berdinskikh, N.K.; Sanina, O.L.; Baraboĭ, V.A.; Starosel'skiĭ, I.V.; Korobko, V.B.; Kamenets, L.I.; Iaremenko, L.I. 1991: The use of ceruloplasmin in combination with adjuvant polychemotherapy in stomach cancer Vrachebnoe Delo 3: 24-27
Stöckle, M. 1994: Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer Der Urologe. Ausg. a 33(6): 568-575
Amiraliev, N.M. 2002: Neoajuvant polychemotherapy at the complex treatment of the patients with laryngeal cancer Antibiotiki i Khimioterapiia 47(3): 22-25
Bondar', G.V.; Kondratiuk, B.P.; Komendant, V.V.; Gonchar, A.G. 1999: Endolymphatic polychemotherapy in comprehensive treatment of pulmonary cancer after a radical surgery Klinichna Khirurhiia 1: 18-20
Sculier, J.P.; Klastersky, J.; Nguyen, N.; Becquart, D.; Vandermoten, G.; Rocmans, P.; Michel, J.; Debusscher, L.; Longeval, E.; Mairesse, M. 1986: Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results Presse Medicale 15(18): 830-834
Frantsiiants, E.M.; Orlovskaia, L.A.; Shalashnaia, E.V.; Mucienko, N.V.; Anapalian, B.K. 1999: Polychemotherapy-induced changes in the antioxidant state of blood in patients with inoperable cancer of the stomach Voprosy Onkologii 45(6): 607-611
Burk, K.; Gropp, C.; de Riese, W.; Löbenau, S. 1985: Experiences with polychemotherapy MAF (mitomycin C, adriablastine, 5-fluorouracil) in progressing metastasized prostate cancer Helvetica Chirurgica Acta 52(3-4): 601-603
Vorob'eva, L.I.; Galakhin, K.A.; Koval'chuk, E.N. 1993: The tumor pathomorphosis and status of the regional lymph nodes after the preoperative polychemotherapy of patients with vulvar cancer Likars'ka Sprava 8: 87-89
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520